{"metadata": {"source": "erowid", "title": "Erowid Fentanyl (China White) Vault", "description": "Information about Fentanyl including uses, images, dosage, effects, legal status, and links to other resources.", "language": "No language found.", "url": "https://www.erowid.org/pharms/fentanyl/fentanyl.shtml", "drug": "Fentanyl", "cid": 3345, "substance": "fentanyl", "category": "PHARMS", "erowid_column": "MainPage", "char_count": 5913, "word_count": 824, "doc_id": "doc_106", "num_chunks": 8, "chunk_id": "106::chunk_5", "document_index": 106, "latency_s": 0.7290845999959856, "prompt_toks": 2012, "completion_toks": 75, "relevance_score": 1.8925148e-05}, "content": "Drug: Fentanyl | cid: 3345\nSource: erowid | Source description: Information about Fentanyl including uses, images, dosage, effects, legal status, and links to other resources.\nErowid name: fentanyl\nCategory: PHARMS\nField: MainPage\n\n                    Text: \n                    Triple Header, by BlackPanther\n\nPatch Overdose and Four Day Hell, by TMG\n\nSolution to all Problems, by Serotone\n\nFrom Relaxing to Overdose to Withdrawal, by Dinar Narlad\n\n» » » MORE » » »\n\nOFF-SITE RESOURCES\n\nPRIMARY RESOURCES #\n\nRxList : Fentanyl (transdermal)\n\nRxList : Fentanyl (oral transmucosal)\n\nSECONDARY RESOURCES #\n\nFentanyl - Wikipedia.org\n\nFentanyl - TripSit.me\n\nMEDIA COVERAGE #\n\nDOJ indicts Chinese fentanyl distributors selling to Americans online - Ars Technica, Oct 17 2017\n\nFentanyl is not a problem. Drug laws are the problem - American Thinker, Dec 15 2016\n\nPrince died from fentanyl overdose, Jun 2, 2016, Minneapolis Star Tribune\n\nBrampton man arrested for allegedly importing fentanyl from China, Sep 8, 2015, CBC.ca\n\nInjured US Marines to get 'lollipop' instead of morphine, Nov 1 2011, Telegraph.co.uk\n\nFentanyl timeline: 1950 through today, Jun 2007, Detroit Free Press\n\nLollipops & Lawsuits, May 2007, Newsweek\n\n\n                    Context: \n                    This section provides recent user experience reports related to fentanyl, including personal overdose stories and recovery insights, along with off-site resources such as primary and secondary reference links, and media coverage highlighting fentanyl's legal, health, and societal impacts. It is relevant for understanding experiential accounts and accessing further information about fentanyl within the broader context of drug information on the webpage.\n                "}
{"metadata": {"source": "psychonaut", "title": "Oxycodone - PsychonautWiki", "description": "Oxycodone (also known under brand names including Roxicodone, OxyContin, Percocet, Oxecta, OxyIR, Endone, Oxynorm, and OxyNEO) is a semi-synthetic opioid synthesized from poppy-derived thebaine. It is a narcotic analgesic within the morphinan chemical class and is generally indicated for relief of moderate to severe pain. It was developed in 1916 in Germany[2][3] as one of several new semi-synthetic opioids in an attempt to improve on the existing opioids.[4]", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Oxycodone", "drug": "Oxycodone", "cid": 5284603, "char_count": 20642, "word_count": 2894, "doc_id": "doc_88", "num_chunks": 28, "chunk_id": "88::chunk_25", "document_index": 88, "latency_s": 0.5753269999986514, "prompt_toks": 5623, "completion_toks": 46, "relevance_score": 1.3631346e-05}, "content": "Drug: Oxycodone | cid: 5284603\nSource: psychonaut | Source description: Oxycodone (also known under brand names including Roxicodone, OxyContin, Percocet, Oxecta, OxyIR, Endone, Oxynorm, and OxyNEO) is a semi-synthetic opioid synthesized from poppy-derived thebaine. It is a narcotic analgesic within the morphinan chemical class and is generally indicated for relief of moderate to severe pain. It was developed in 1916 in Germany[2][3] as one of several new semi-synthetic opioids in an attempt to improve on the existing opioids.[4]\n\n                    Text: \n                    ↑ Why Heroin Relapse Often Ends In Death - Lauren F Friedman (Business Insider) | http://www.businessinsider.com.au/philip-seymour-hoffman-overdose-2014-2\n\n↑ Siegel, S., Hinson, R. E., Krank, M. D., McCully, J. (23 April 1982). \"Heroin \"Overdose\" Death: Contribution of Drug-Associated Environmental Cues\". Science. 216 (4544): 436–437. doi:10.1126/science.7200260. ISSN 0036-8075.\n\n↑ 10.0 10.1 Ershad, M., Cruz, M. D., Mostafa, A., Mckeever, R., Vearrier, D., Greenberg, M. I. (March 2020). \"Opioid Toxidrome Following Grapefruit Juice Consumption in the Setting of Methadone Maintenance\". Journal of Addiction Medicine. 14 (2): 172–174. doi:10.1097/ADM.0000000000000535. ISSN 1932-0620.\n\n↑ VI.8a Convention for limiting the Manufacture and regulating the Distribution of Narcotic Drugs. Geneva, 13 July 1931 | https://treaties.un.org/doc/Treaties/1931/07/19310713%2006-44%20AM/Ch_VI_8_ap.pdf\n\n\n                    Context: \n                    This excerpt provides references and citations related to the dangers of heroin overdose, environmental factors influencing overdose risk, and international drug treaties, highlighting legal regulations and the complexities of opioid-related fatalities discussed in the full document on oxycodone.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid LSD (Acid) Vault : FAQ", "description": "Frequently Asked Questions about LSD", "language": "No language found.", "url": "https://www.erowid.org/chemicals/lsd/lsd_faq.shtml", "drug": "LSD", "cid": 5761, "substance": "lsd", "category": "CHEMICALS", "erowid_column": "FAQ", "char_count": 70642, "word_count": 10952, "doc_id": "doc_156", "num_chunks": 103, "chunk_id": "156::chunk_61", "document_index": 156, "latency_s": 1.53104020000319, "prompt_toks": 16418, "completion_toks": 68, "relevance_score": 8.8011e-06}, "content": "Drug: LSD | cid: 5761\nSource: erowid | Source description: Frequently Asked Questions about LSD\nErowid name: lsd\nCategory: CHEMICALS\nField: FAQ\n\n                    Text: \n                    his young friends decided to take LSD, and he felt obliged to dissemble his fears and join them; it was his first and only trip. He felt a panic he had never known before; he thought that he was losing his mind and going \"out of control.\" His friends were so concerned that they took him to a small hospital, where he was given chlorpromazine and after six hours released in their care. The next day he had a flashback that lasted one or two hours and was almost as frightening as the original experience. Flashbacks continued for six months, their frequency, duration, and severity eventually diminishing to the point where it was difficult for him to determine whether they were related to the LSD trip or merely an intensification of his usual anxiety. In fact, the patient described the flashbacks as being like very much enhanced anxiety episodes. Even several years after this experience, when he became very anxious, he was reminded of the trip and these flashbacks. He denied that these\n\n\n                    Context: \n                    This excerpt details a case of LSD-induced panic, hospitalization, and a prolonged six-month period of frightening flashbacks that were later linked to underlying anxiety. It highlights potential psychological adverse effects, such as anxiety and flashbacks, in the broader context of the document's discussion on LSD risks, bad trips, and individual reactions to psychedelic use.\n                "}
